Therapeutic Asset Ratings
407 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
EXEMESTANE
Locally Advanced Malignant Neoplasm
Merck Sharp & Dohme LLC
P3
BB
(65)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
CD20-positive Follicular Lymphoma, With Low Tumour Burden
Merck Sharp & Dohme LLC
P3
BB
(65)
Cyclophosphamide
Gall Bladder Cancer
Merck Sharp & Dohme LLC
P2
BB
(65)
Docetaxel
Gall Bladder Cancer
Merck Sharp & Dohme LLC
P2
BB
(65)
Epirubicin
Gall Bladder Cancer
Merck Sharp & Dohme LLC
P2
BB
(65)
Epirubicin
Lymphoma
Merck Sharp & Dohme LLC
P4
BB
(64)
Palbociclib
Renal Cell Carcinoma
Merck Sharp & Dohme LLC
P4
BB
(64)
Sra-333
Schizophrenia
Merck Sharp & Dohme LLC
P4
BB
(64)
Abiraterone Acetate
Metastasis
Merck Sharp & Dohme LLC
P3
BB
(64)
Belzutifan
Von Hippel-Lindau Disease
Merck Sharp & Dohme LLC
P3
BB
(64)
CIS-DIAMMINEDICHLOROPLATINUM II
Ovarian Neoplasms
Merck Sharp & Dohme LLC
P3
BB
(64)
IMMUNOGLOBULIN G1, ANTI-(HUMAN CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED ANTIGEN 4) (HUMAN-MUS MUSCULUS MONOCLONAL M3 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL M3 .KAPPA.-CHAIN, DIMER
Carcinoma, Renal Cell
Merck Sharp & Dohme LLC
P3
BB
(64)
Levoleucovorin
Colon Adenocarcinoma
Merck Sharp & Dohme LLC
P3
BB
(64)
Nemtabrutinib
Chronic Lymphocytic Leukaemia
Merck Sharp & Dohme LLC
P3
BB
(64)
Zilovertamab Vedotin
Diffuse Large B-cell Lymphoma
Merck Sharp & Dohme LLC
P3
BB
(64)
Carboplatin
Gallbladder Cancer
Merck Sharp & Dohme LLC
P2
BB
(64)
Efinopegdutide
Hepatic Impairment
Merck Sharp & Dohme LLC
P2
BB
(64)
Irinotecan
Urinary Bladder Neoplasms
Merck Sharp & Dohme LLC
P2
BB
(64)
Cyclophosphamide
Merkel Cell Carcinoma
Merck Sharp & Dohme LLC
P2/3
BB
(64)
Olaparib
Peritoneal Neoplasms
Merck Sharp & Dohme LLC
P3
B
(63)
Cyclophosphamide
Cutaneous Squamous Cell Carcinoma
Merck Sharp & Dohme LLC
P2
B
(63)
Pembrolizumab
Gall Bladder Cancer
Merck Sharp & Dohme LLC
P2
B
(63)
(+)-VINCRISTINE
Urinary Bladder Neoplasms
Merck Sharp & Dohme LLC
P2
B
(63)
Benadryl
Prostate Neoplasm
Merck Sharp & Dohme LLC
P3
B
(62)
Carboplatin
Cervical Cancer
Merck Sharp & Dohme LLC
P3
B
(62)
Showing 51 to 75 of 407 assets
Previous
Page 3 of 17
Next